Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer
Conditions
- Adenocarcinoma of the Prostate
- Stage II Prostate Cancer
- Stage III Prostate Cancer
Interventions
- DRUG: sorafenib tosylate
- GENETIC: microarray analysis
- OTHER: immunohistochemistry staining method
- GENETIC: gene expression analysis
- PROCEDURE: needle biopsy
- PROCEDURE: therapeutic conventional surgery
- OTHER: laboratory biomarker analysis
- GENETIC: western blotting
- GENETIC: RNA analysis
Sponsor
University of Washington
Collaborators